NASDAQ : ISPC
iSpecimen Inc. — Financial statements
Healthcare · Diagnostics & Research · United States
Last price 0.7923 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.00M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
iSpecimen Inc. (ISPC) reported revenue of 466.30K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 466.30K | 1.93M | 9.29M | 9.93M | 10.40M | 11.14M |
| Cost of Revenue | 971.13K | 1.90M | 5.30M | 4.82M | 4.76M | 5.25M |
| Gross Profit | -504.83K | 24.11K | 3.99M | 5.11M | 5.65M | 5.89M |
| Selling, General & Admin | 7.28M | 6.84M | 13.19M | 12.71M | 13.18M | 9.97M |
| Research & Development | 1.63M | 2.16M | 3.53M | 3.57M | 2.66M | 1.84M |
| Operating Expenses | 8.91M | 9.00M | 16.72M | 16.28M | 15.83M | 11.81M |
| Operating Income | -9.42M | -8.98M | -12.73M | -11.17M | -10.19M | -5.93M |
| Interest Expense | -305.00 | -9.92K | -220.07K | -230.78K | -238.96K | -2.10M |
| Interest & Investment Income | 1.12K | 3.75K | 44.13K | 339.75K | 169.34K | 11.40K |
| Other Non Operating Income (Expenses) | -2.00M | -1.50M | 406.18K | -39.10K | 9.78K | 1.27M |
| EBT Excluding Unusual Items | -11.42M | -10.49M | -12.50M | -11.10M | -10.25M | -6.75M |
| Other Unusual Items | -2.21M | |||||
| Pretax Income | -11.42M | -10.49M | -12.50M | -11.10M | -10.25M | -8.96M |
| Net Income | -11.42M | -10.49M | -12.50M | -11.10M | -10.25M | -8.96M |
| Net Income to Common | -11.42M | -10.49M | -12.50M | -11.10M | -10.25M | -8.96M |
| Shares Outstanding (Basic) | 520.36K | 115.06K | 17.77K | 11.30K | 11.05K | |
| Shares Outstanding (Diluted) | 520.36K | 115.06K | 17.77K | 11.30K | 11.05K | |
| EPS (Basic) | -21.95 | -91.15 | -703.27 | -982.08 | -926.81 | |
| EPS (Diluted) | -21.95 | -91.15 | -703.27 | -982.08 | -928.00 | |
| Free Cash Flow | -7.00M | -4.24M | -8.32M | -5.83M | -6.03M | -10.67M |
| Free Cash Flow Per Share | -13.46 | -36.86 | -468.19 | -515.58 | -545.75 | |
| Gross Margin | -108.26% | 1.25% | 42.93% | 51.45% | 54.27% | 52.86% |
| Operating Margin | -2,020.04% | -465.42% | -136.99% | -112.50% | -97.92% | -53.21% |
| Profit Margin | -2,449.04% | -543.68% | -134.51% | -111.80% | -98.50% | -80.48% |
| Free Cash Flow Margin | -1,502.03% | -219.86% | -89.55% | -58.69% | -58.00% | -95.83% |
| EBITDA | -9.28M | -8.72M | -12.47M | -11.00M | -10.16M | -5.88M |
| EBITDA Margin | -134.22% | -110.82% | -97.71% | -52.80% | ||
| D&A For EBITDA | 134.56K | 260.03K | 257.27K | 167.06K | 22.43K | 45.36K |
| EBIT | -9.42M | -8.98M | -12.73M | -11.17M | -10.19M | -5.93M |
| EBIT Margin | -136.99% | -112.50% | -97.92% | -53.21% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.41M | 6.88M | 1.88M | 2.34M | 15.31M | 27.74M |
| Short-Term Investments | 2.66M | |||||
| Cash & Short-Term Investments | 4.41M | 6.88M | 1.88M | 5.01M | 15.31M | 27.74M |
| Accounts Receivable | 21.26K | 48.30K | 1.44M | 2.94M | 3.93M | 4.74M |
| Other Receivables | 140.87K | 140.87K | ||||
| Receivables | 21.26K | 48.30K | 1.44M | 2.94M | 4.07M | 4.88M |
| Inventory | 45.11K | |||||
| Prepaid Expenses | 48.94K | 25.46K | 219.78K | 292.08K | 300.43K | 327.04K |
| Total Current Assets | 4.48M | 6.95M | 3.59M | 8.24M | 19.68M | 32.95M |
| Property, Plant & Equipment | 259.40K | 294.70K | 421.54K | 321.64K | 410.54K | 32.78K |
| Other Intangible Assets | 2.64M | 2.27M | 5.33M | 7.23M | 4.50M | 2.71M |
| Other Long-Term Assets | 12.10K | 12.10K | 12.10K | 27.60K | 27.60K | 27.60K |
| Total Assets | 7.39M | 9.53M | 9.35M | 15.82M | 24.62M | 35.72M |
| Accounts Payable | 4.67M | 5.36M | 4.20M | 3.93M | 2.46M | 832.68K |
| Accrued Expenses | 619.27K | 619.24K | 1.17M | 1.54M | 1.53M | 1.02M |
| Current Portion of Leases | 61.18K | 56.92K | 43.37K | 167.11K | 158.45K | |
| Current Unearned Revenue | 124.70K | 192.53K | 360.71K | 415.77K | 132.34K | 654.75K |
| Total Current Liabilities | 5.48M | 6.23M | 5.77M | 6.05M | 4.28M | 2.51M |
| Long-Term Debt | 3.42M | |||||
| Long-Term Leases | 179.72K | 211.87K | 268.80K | 29.13K | 27.40K | |
| Total Liabilities | 5.66M | 6.44M | 6.04M | 6.08M | 4.31M | 5.93M |
| Common Stock | 152.00 | 848.00 | 170.00 | 45.00 | 892.00 | 873.00 |
| Additional Paid-In Capital | 87.72M | 85.44M | 75.17M | 69.11M | 68.57M | 67.81M |
| Retained Earnings | -85.99M | -82.35M | -71.86M | -59.36M | -48.27M | -38.02M |
| Treasury Stock | -172.00 | -172.00 | -172.00 | -172.00 | -172.00 | -172.00 |
| Comprehensive Income & Other | 840.00 | |||||
| Total Common Equity | 1.74M | 3.09M | 3.31M | 9.74M | 20.31M | 29.79M |
| Shareholders' Equity | 1.74M | 3.09M | 3.31M | 9.74M | 20.31M | 29.79M |
| Total Liabilities & Equity | 7.39M | 9.53M | 9.35M | 15.82M | 24.62M | 35.72M |
| Total Debt | 240.90K | 268.80K | 312.17K | 196.24K | 185.85K | 3.42M |
| Net Cash (Debt) | 4.17M | 6.61M | 1.57M | 4.81M | 15.12M | 24.32M |
| Net Cash Per Share | 8.02 | 57.46 | 88.13 | 425.53 | 1,367.97 | |
| Filing Date Shares Outstanding | 2.52M | 741.56K | 62.42K | 11.32K | 11.23K | 10.98K |
| Total Common Shares Outstanding | 1.52M | 211.97K | 42.42K | 11.35K | 11.16K | 10.92K |
| Working Capital | -992.54K | 723.28K | -2.18M | 2.19M | 15.39M | 30.44M |
| Book Value Per Share | 1.14 | 14.57 | 78.05 | 857.94 | 1,820.31 | 2,728.92 |
| Tangible Book Value | -900.76K | 818.21K | -2.02M | 2.51M | 15.81M | 27.08M |
| Tangible Book Value Per Share | -0.59 | 3.86 | -47.56 | 221.05 | 1,416.63 | 2,480.60 |
| Machinery | 138.06K | 138.06K | 137.60K | 218.67K | 207.22K | 207.22K |
| Leasehold Improvements | 12.65K | 12.65K | 12.65K | 68.47K | 60.44K | 24.93K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -11.42M | -10.49M | -12.50M | -11.10M | -10.25M | -8.96M |
| Depreciation & Amortization | 134.56K | 260.03K | 257.27K | 167.06K | 22.43K | 45.36K |
| Other Amortization | 1.07M | 1.47M | 2.04M | 1.95M | 1.26M | 1.83M |
| Loss (Gain) From Sale of Assets | 58.00 | |||||
| Asset Writedown & Restructuring Costs | 2.40M | 2.40M | 327.39K | |||
| Loss (Gain) From Sale of Investments | 680.00 | |||||
| Stock-Based Compensation | 4.74K | 21.27K | 249.68K | 459.67K | 684.86K | 634.56K |
| Provision & Write-off of Bad Debts | 38.71K | 59.86K | 1.89M | 305.04K | 106.58K | 161.07K |
| Other Operating Activities | -336.52K | -75.00K | -28.98K | -177.29K | 900.75K | |
| Change in Accounts Receivable | 312.50K | 1.34M | -397.40K | 679.74K | 709.18K | -2.72M |
| Change in Inventory | 45.11K | 45.11K | ||||
| Change in Accounts Payable | 693.47K | 1.24M | 272.12K | 1.47M | 1.63M | -959.75K |
| Change in Unearned Revenue | -39.37K | -168.17K | -55.06K | 283.44K | -522.41K | -218.51K |
| Change in Other Net Operating Assets | 98.21K | -339.77K | -322.33K | 18.96K | 541.02K | -1.42M |
| Operating Cash Flow | -7.00M | -4.24M | -8.26M | -5.81M | -5.82M | -10.67M |
| Capital Expenditures | -454.00 | -56.55K | -19.48K | -215.50K | -2.55K | |
| Sale (Purchase) of Intangibles | -1.70M | -1.00M | -653.29K | -4.73M | -2.98M | -1.04M |
| Investment in Securities | 2.69M | -2.48M | ||||
| Investing Cash Flow | -1.70M | -1.00M | 1.98M | -7.23M | -3.19M | -1.04M |
| Long-Term Debt Issued | 4.00M | |||||
| Total Debt Issued | 4.00M | |||||
| Long-Term Debt Repaid | -3.50M | -3.00M | ||||
| Net Debt Issued (Repaid) | -3.50M | 1.00M | ||||
| Issuance of Common Stock | 8.25M | 5.75M | 6.49M | 70.89K | 78.64K | 41.76M |
| Repurchase of Common Stock | -52.50K | |||||
| Other Financing Activities | -1.22M | -1.01M | -621.48K | -4.01M | ||
| Financing Cash Flow | 12.53M | 10.24M | 5.82M | 70.89K | -3.42M | 38.75M |
| Net Cash Flow | 3.83M | 5.00M | -465.26K | -12.97M | -12.43M | 27.04M |
| Free Cash Flow | -7.00M | -4.24M | -8.32M | -5.83M | -6.03M | -10.67M |
| Free Cash Flow Margin | -1,502.03% | -219.86% | -89.55% | -58.69% | -58.00% | -95.83% |
| Free Cash Flow Per Share | -13.46 | -36.86 | -468.19 | -515.58 | -545.75 | |
| Levered Free Cash Flow | -5.58M | -2.78M | -4.89M | -6.40M | -5.28M | -13.02M |
| Unlevered Free Cash Flow | -5.58M | -2.78M | -4.75M | -6.26M | -5.21M | -12.58M |
| Cash Interest Paid | 2.00 | 1.95K | 14.36K | 16.00K | 161.58K | 2.82M |
| Change in Working Capital | 1.11M | 2.11M | -502.67K | 2.59M | 2.35M | -5.28M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.10M | 2.54M | 2.56M | 4.54M | 12.26M | 68.07M |
| Enterprise Value | -2.08M | 40.12K | 1.99M | -885.14K | -4.74M | 61.70M |
| Last Close Price | 0.83 | 10.40 | 106.20 | 400.48 | 1,100.00 | 6,248.00 |
| PS Ratio | 4.43 | 1.32 | 0.28 | 0.46 | 1.18 | 6.11 |
| PB Ratio | 0.72 | 0.82 | 0.77 | 0.47 | 0.60 | 2.29 |
| P/TBV Ratio | 3.11 | 1.81 | 0.78 | 2.51 | ||
| EV/Sales Ratio | 0.02 | 0.21 | 5.54 | |||
| Debt / Equity Ratio | 0.14 | 0.09 | 0.09 | 0.02 | 0.01 | 0.12 |
| Net Debt / Equity Ratio | -2.40 | -2.14 | -0.47 | -0.49 | -0.74 | -0.82 |
| Net Debt / EBITDA Ratio | 0.45 | 0.76 | 0.13 | 0.44 | 1.49 | 4.14 |
| Net Debt / FCF Ratio | 0.60 | 1.56 | 0.19 | 0.82 | 2.51 | 2.28 |
| Asset Turnover | 0.07 | 0.20 | 0.74 | 0.49 | 0.34 | 0.53 |
| Quick Ratio | 0.81 | 1.11 | 0.58 | 1.31 | 4.53 | 13.02 |
| Current Ratio | 0.82 | 1.12 | 0.62 | 1.36 | 4.60 | 13.15 |
| Return on Equity (ROE) | -968.47% | -327.77% | -191.51% | -73.87% | -40.90% | -130.96% |
| Return on Assets (ROA) | -87.69% | -59.44% | -63.21% | -34.53% | -21.10% | -17.66% |
| Return on Capital Employed (ROCE) | -491.60% | -272.00% | -355.60% | -114.30% | -50.10% | -17.80% |
| Earnings Yield | -2,636.81% | -412.66% | -489.02% | -244.32% | -83.55% | -13.17% |
| FCF Yield | -338.68% | -166.88% | -325.56% | -128.26% | -49.20% | -15.68% |
| Buyback Yield / Dilution | -1,153.73% | -547.47% | -57.24% | -2.23% |